From Casetext: Smarter Legal Research

Nordisk v. Caraco Pharm. Labs., Ltd.

United States Court of Appeals for the Federal Circuit
Aug 15, 2012
2011-1223 (Fed. Cir. Aug. 15, 2012)

Opinion

2011-1223 2012-1031

08-15-2012

NOVO NORDISK A/S AND NOVO NORDISK INC., Plaintiffs-Appellants, v. CARACO PHARMACEUTICAL LABORATORIES, LTD. AND SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellees. NOVO NORDISK INC. AND NOVO NORDISK A/S, Plaintiffs-Appellants, v. PADDOCK LABORATORIES, INC., Defendant-Appellee.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the Eastern District of Michigan in case no. 05-CY-40188, Judge Avern Cohn.

Appeal from the United States District Court for the District of Minnesota in case no. 10-CV-2199, Judge Donovan W. Frank.

ON MOTION


ORDER

Novo Nordisk et al. submit responses and motions concerning how these cases should proceed.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motions are granted to the extent that the stays of the briefing schedules are lifted in the two above-captioned appeals. The appellant's opening brief in each appeal is due within 40 days of the date of filing of this order.

(2) Appeal 2011-1223 and 2012-1031 will be treated as companion cases, i.e., they will be argued consecutively before the same merits panel.

FOR THE COURT

________________________

Jan Horbaly

Clerk
cc: Daniel G. Brown, Esq.

James F. Hurst, Esq.

Mark A. Perry, Esq.

s8


Summaries of

Nordisk v. Caraco Pharm. Labs., Ltd.

United States Court of Appeals for the Federal Circuit
Aug 15, 2012
2011-1223 (Fed. Cir. Aug. 15, 2012)
Case details for

Nordisk v. Caraco Pharm. Labs., Ltd.

Case Details

Full title:NOVO NORDISK A/S AND NOVO NORDISK INC., Plaintiffs-Appellants, v. CARACO…

Court:United States Court of Appeals for the Federal Circuit

Date published: Aug 15, 2012

Citations

2011-1223 (Fed. Cir. Aug. 15, 2012)